Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Background: The emergence of antifungal resistance threatens effective treatment of invasive fungal infection (IFI). Invasive candidiasis is the most common health care–associated IFI. We evaluated the activity of fluconazole (FLU) against 20 788 invasive isolates of Candida (37 species) collected from 135 medical centers in 39 countries (1997–2016). The activity of anidulafungin, caspofungin, and micafungin (MCF) was evaluated against 15 308 isolates worldwide (2006–2016). Methods: Species identification was accomplished using phenotypic (1997–2001), genotypic, and proteomic methods (2006–2016). All isolates were tested using reference methods and clinical breakpoints published in the Clinical and Laboratory Standards Institute documents. Results: A decrease in the isolation of Candida albicans and an increase in the isolation of Candida glabrata and Candida parapsilosis were observed over time. Candida glabrata was the most common non–C. albicans species detected in all geographic regions except for Latin America, where C. parapsilosis and Candida tropicalis were more common. Six Candida auris isolates were detected: 1 each in 2009, 2013, 2014, and 2015 and 2 in 2016; all were from nosocomial bloodstream infections and were FLU-resistant (R). The highest rates of FLU-R isolates were seen in C. glabrata from North America (NA; 10.6%) and in C. tropicalis from the Asia-Pacific region (9.2%). A steady increase in isolation of C. glabrata and resistance to FLU was detected over 20 years in the United States. Echinocandin-R (EC-R) ranged from 3.5% for C. glabrata to 0.1% for C. albicans and C. parapsilosis. Resistance to MCF was highest among C. glabrata (2.8%) and C. tropicalis (1.3%) from NA. Mutations on FKS hot spot (HS) regions were detected among 70 EC-R isolates (51/70 were C. glabrata). Most isolates harboring FKS HS mutations were resistant to 2 or more ECs. Conclusions: EC-R and FLU-R remain uncommon among contemporary Candida isolates; however, a slow and steady emergence of resistance to both antifungal classes was observed in C. glabrata and C. tropicalis isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Historically this organism has been pan-susceptible to triazoles, echinocandins, and amphotericin B.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although relatively low levels of resistance for most Candida species have been described, the outcomes for candidemia remain poor, as high levels of mortality (15%-50%) have been associated with candida infections7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this Review, we explore the molecular mechanisms that contribute to antifungal drug resistance, with a focus on Candida spp., the most common cause of fungal infections in humans7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Sentinel surveillance programs designed to capture organisms and patient demographic data from representative sites spanning a larger geographical area and over a longer period of time serve to fill the gaps in time and space that are necessarily left by the more intensive and focused, yet intermittent, population-bas…”
BackgroundSelf-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · cited 1×
“The burden of invasive fungal infections (IFIs) for patients and health care systems is difficult to measure [2, 12]; however, it is well recognized that IFIs are associated with high morbidity and mortality rates and elevated health care costs.”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 2×
“S90 • OFID 2019:6 (Suppl 1) • Pfaller et al SENTRY Program Candida Surveillance (1997–2016) • OFID 2019:6 (Suppl 1) • S91 [93, 94], and emerging resistance mechanisms [20, 68] highlight the importance of local and global surveillance studies.”
BackgroundSelf-citationKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 1×
“Caspofungin, micafungin, and anidulafungin were approved for clinical use by the US Food and Drug Administration (FDA) in 2001, 2005, and 2006, respectively, and are now recommended as firstline agents for treating IC [50, 67].”
BackgroundCalderone, R. (2012) · ASM Press eBooks · Cited by 912
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Self-citation
Research works printed but not linked: 4
- 38. CLSI. M27-S4. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: 4th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
- 39. CLSI. M27-A3. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- 40. CLSI. M59. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 1st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
- 63. Pfaller MA, Diekema DJ Azole antifungal drug cross-resistance: mechanisms epidemiology, and clinical significance. J Invasive Fungal Infect 2007; 1: 74– 92.
Cited by
Items 101–200 of 931
Update on therapeutic approaches for invasive fungal infections in adults
Boutin, C.-A., & Luong, M. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231224980 · Cited by 54
Al-Baqsami, Z. F., Ahmad, S., & Khan, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-63240-z · Cited by 49
Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W., & Li, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01401 · Cited by 46
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans
Todd, R. T., Soisangwan, N., Peters, S., Kemp, B., Crooks, T., Gerstein, A., & Selmecki, A. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad009 · Cited by 53
“Invasive fungal infections caused by opportunistic and recently emerged fungal pathogens are associated with high mortality rates and increased healthcare-associated costs, particularly in immunocompromised patients (Patterson 2002; Pfaller 2012; Pfaller et al. 2019).”
InfluentialVázquez-Muñoz, R., Thompson, A. K., Russell, J. T., Sobue, T., Zhou, Y., & Dongari‐Bagtzoglou, A. I. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.853762 · Cited by 53
Mohsin, J., Weerakoon, S., Ahmed, S., Puts, Y., Al Balushi, Z., Meis, J. F., & Al-Hatmi, A. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9100638 · Cited by 43
McCarty, T. P., & Pappas, P. G. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.732223 · Cited by 53
Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression
Wang, D., An, N., Yang, Y., Yang, X., Fan, Y., & Feng, J. (2021) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-021-00890-2 · Cited by 52
Poon, Y., & Hui, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1105949 · Cited by 52
Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 51
The Epidemiology and Susceptibility of Candidemia in Jerusalem, Israel
Israel, S., Amit, S., Israel, A., Livneh, A., Nir‐Paz, R., & Korem, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00352 · Cited by 51
Arastehfar, A., Kargar, M. L., Mohammadi, S. R., Roudbary, M., Ghods, N., Haghighi, L., Daneshnia, F., Tavakoli, M., Jafarzadeh, J., Hedayati, M. T., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.655069 · Cited by 41
Hoenigl, M., Sprute, R., Arastehfar, A., Perfect, J. R., Lass-Flörl, C., Bellmann, R., Prattes, J., Thompson, G. R., Wiederhold, N. P., Al Obaidi, M. M., et al. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2086120 · Cited by 45
Wu, M., Xu, X., Hu, R. M., Chen, Q., Chen, L., Yuan, Y., Li, J., Zhou, L., Feng, S., Wang, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202207736 · Cited by 50
Ceballos-Garzón, A., Peñuela, A., Valderrama, S., Vargas‐Casanova, Y., Ariza, B., & Parra‐Giraldo, C. M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1136217 · Cited by 49
Arastehfar, A., Daneshnia, F., Salehi, M., Yaşar, M., Hoşbul, T., Ilkit, M., Pan, W., Hagen, F., Arslan, N., Türk‐Dağı, H., et al. (2020) · Mycoses · doi:10.1111/myc.13104 · Cited by 42
Continual decline in azole susceptibility rates in candida tropicalis over a 9-year period in China
Wang, Y., Fan, X., Wang, H., Kudinha, T., Mei, Y.-N., Ni, F., Pan, Y.-H., Gao, L.-M., Xu, H., Kong, H.-S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.702839 · Cited by 47
Yong, J., Zu, R., Huang, X., Ge, Y., & Li, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01498 · Cited by 47
Kim, E. J., Lee, E., Kwak, Y. G., Yoo, H. M., Choi, J. Y., Kim, S. R., Shin, M. J., Yoo, S.-Y., Cho, N.-H., & Choi, Y. H. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606976 · Cited by 47
Opportunistic yeast pathogen Candida spp.: Secreted and membrane-bound virulence factors
Lim, S. J., Ali, M. S. M., Sabri, S., Noor, N. D. M., Salleh, A. B., & Oslan, S. N. (2021) · Medical Mycology · doi:10.1093/mmy/myab053 · Cited by 47
Quindós, G., Miranda-Cadena, K., San-Millán, R., Borroto–Esoda, K., Cantón, E., Linares-Sicilia, M. J., Hamprecht, A. G., Montesinos, I., Tortorano, A. M., Prigitano, A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.906563 · Cited by 46
A synthetic peptide mimic kills Candida albicans and synergistically prevents infection
Schaefer, S., Vij, R., Sprague, J. L., Austermeier, S., Dinh, H., Judzewitsch, P. R., Müller‐Loennies, S., Silva, T. L., Seemann, E. A., Qualmann, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50491-x · Cited by 45
Mechanistic insights into Candida biofilm eradication potential of eucalyptol
Gupta, P., Pruthi, V., & Poluri, K. M. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14940 · Cited by 45
Carvalhaes, C. G., Klauer, A. L., Rhomberg, P. R., Pfaller, M. A., & Castanheira, M. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02449-21 · Cited by 45
Self-citationDesnos-Ollivier, M., Lortholary, O., Bretagne, S., & Dromer, F. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-20 · Cited by 44
“parapsilosis isolates similar to that reported in international surveys (17, 19, 20, 28, 44).”
ResultThe Candida Genome Database: annotation and visualization updates
Lew-Smith, J., Binkley, J., & Sherlock, G. (2025) · Genetics · doi:10.1093/genetics/iyaf001 · Cited by 44
Identification of Cryptic Species of Four Candida Complexes in a Culture Collection
Fontecha, G. A., Montes, K., Ortíz, B., Galindo, C., & Braham, S. (2019) · Journal of Fungi · doi:10.3390/jof5040117 · Cited by 44
Plant-Derived Substances in the Fight Against Infections Caused by Candida Species
Guevara-Lora, I., Braś, G., Karkowska‐Kuleta, J., Gonzalez‐Gonzalez, M., Ceballos, K., Sidlo, W., & Rąpała‐Kozik, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176131 · Cited by 44
Advances in fungal chemical genomics for the discovery of new antifungal agents
Xue, A., Robbins, N., & Cowen, L. E. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14484 · Cited by 43
Demirci‐Duarte, S., Arıkan-Akdağlı, S., & Gülmez, D. (2021) · Mycoses · doi:10.1111/myc.13296 · Cited by 43
Beyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens
Yang, F., & Berman, J. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102439 · Cited by 42
Immune response in bacterial and Candida sepsis
Patricio, P., Paiva, J. A., & Borrego, L. M. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00011 · Cited by 42
Papp, C., Bohner, F., Kocsis, K., Varga, M., Szekeres, A., Bodai, L., Willis, J. R., Gabaldón, T., Tóth, R., Nosanchuk, J. D., et al. (2020) · mSphere · doi:10.1128/msphere.00821-20 · Cited by 42
Farnesol increases the activity of echinocandins against Candida auris biofilms
Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A. M., Majoros, L., & Kovács, R. (2019) · Medical Mycology · doi:10.1093/mmy/myz057 · Cited by 42
Brunetti, G., Navazio, A. S., Giuliani, A., Giordano, A., Proli, E. M., Antonelli, G., & Raponi, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224678 · Cited by 43
Simonicova, L., & Moye-Rowley, W. S. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1009005 · Cited by 45
On the Origin of Candida auris: Ancestor, Environmental Stresses, and Antiseptics
Sharma, M., & Chakrabarti, A. (2020) · mBio · doi:10.1128/mbio.02102-20 · Cited by 35
Gupta, P., Goel, A., Singh, K. R., Meher, M. K., Gulati, K., & Poluri, K. M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.035 · Cited by 41
Liu, F., Zhong, L., Zhou, F., Zheng, C., Zhang, K., Cai, J., Zhou, H., Tang, K., Dong, Z., Cui, W., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s323583 · Cited by 41
Pezzotti, G., Kobara, M., Nakaya, T., Imamura, H., Miyamoto, N., Adachi, T., Yamamoto, T., Kanamura, N., Ohgitani, E., Marin, E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105359 · Cited by 41
Arastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F., Yaşar, M., Arslan, N., Hoşbul, T., Ünal, N., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587278 · Cited by 40
Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Aneuploidy and gene dosage regulate filamentation and host colonization by Candida albicans
Kakade, P., Sircaik, S., Maufrais, C., Ene, I. V., & Bennett, R. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218163120 · Cited by 40
What Is New in Fungal Infections?
Parsons, M. G., & Diekema, D. J. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100187 · Cited by 40
Self-citationNovel evidence on sepsis-inducing pathogens: from laboratory to bedside
Gatica, S., Fuentes, B., Rivera-Asín, E., Ramírez-Céspedes, P., Sepúlveda-Alfaro, J., Catalán, E. A., Bueno, S. M., Kalergis, A. M., Simón, F., Riedel, C. A., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1198200 · Cited by 41
Critical appraisal beyond clinical guidelines for intraabdominal candidiasis
Maseda, E., Martín‐Loeches, I., Zaragoza, R., Pemán, J., Fortün, J., Grau, S., Aguilar, G., Varela, M., Borges-Sa, M., Giménez, M.-J., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04673-6 · Cited by 40
Díaz-García, J., Mesquida, A., Sánchez-Carrillo, C., Reigadas, E., Muñoz, P., Escribano, P., & Guinea, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01827-20 · Cited by 39
Fungal Colonization and Infections—Interactions with Other Human Diseases
Mahalingam, S. S., Jayaraman, S., & Pandiyan, P. (2022) · Pathogens · doi:10.3390/pathogens11020212 · Cited by 40
Candida auris: the new fungal threat.
Pallotta, F., Viale, P., & Barchiesi, F. (2023) · PubMed Central · doi:10.53854/liim-3103-6 · Cited by 40
Al-Obaid, I., Asadzadeh, M., Ahmad, S., Alobaid, K., Alfouzan, W., Bafna, R., Emara, M., & Joseph, L. (2022) · Journal of Fungi · doi:10.3390/jof8030267 · Cited by 39
Vu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, W. S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009582 · Cited by 39
Gașpar, B. S., Roşu, O. A., Enache, R. M., Profir, M., Pavelescu, L. A., & Creţoiu, S. M. (2025) · Journal of Fungi · doi:10.3390/jof11050333 · Cited by 40
de Oliveira, J. S., Pereira, V. S., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Sidrim, J. J. C., Brilhante, R. S. N., & Rocha, M. F. G. (2020) · Canadian Journal of Microbiology · doi:10.1139/cjm-2019-0531 · Cited by 39
McTaggart, L. R., Cabrera, A. L., Cronin, K. I., & Kus, J. V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-20 · Cited by 39
Pfaller, M. A., Messer, S. A., Deshpande, L. M., Rhomberg, P. R., Utt, E. A., & Castanheira, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02031-20 · Cited by 37
Self-citationDetection and Molecular Identification of Eight Candida Species in Clinical Samples by Simplex PCR
García-Salazar, E., Acosta‐Altamirano, G., Betancourt-Cisneros, P., Reyes-Montes, M. D. R., de Paz, E. R., Duarte-Escalante, E., Sánchez-Conejo, A. R., Hernández, E. O., & León, M. G. F.-D. (2022) · Microorganisms · doi:10.3390/microorganisms10020374 · Cited by 39
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
Astvad, K. M. T., Arıkan-Akdağlı, S., & Arendrup, M. C. (2022) · Journal of Fungi · doi:10.3390/jof8020141 · Cited by 40
Esmaeili, A., Saleh, I., & Abu‐Dieyeh, M. H. (2025) · Phytochemistry Reviews · doi:10.1007/s11101-025-10093-x · Cited by 38
Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans
Xu, Y., Lu, H., Zhu, S., Li, W.-Q., Jiang, Y.-Y., Berman, J., & Yang, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00321-21 · Cited by 35
Galia, L., Pezzani, M. D., Compri, M., Callegari, A., Rajendran, N. B., Carrara, E., Tacconelli, E., & the COMBACTE MAGNET EPI-Net Network (2022) · Journal of Fungi · doi:10.3390/jof8030249 · Cited by 39
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey
Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab471 · Cited by 37
Epigenetic Regulation of Antifungal Drug Resistance
Patra, S., Raney, M., Pareek, A., & Kaur, R. (2022) · Journal of Fungi · doi:10.3390/jof8080875 · Cited by 38
Keyvanfar, A., Najafiarab, H., Talebian, N., Tafti, M. F., Adeli, G., Ghasemi, Z., & Tehrani, S. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09442-6 · Cited by 37
PDR-like ABC systems in pathogenic fungi
Moréno, A., Banerjee, A., Prasad, R., & Falson, P. (2019) · Research in Microbiology · doi:10.1016/j.resmic.2019.09.002 · Cited by 37
Posteraro, B., Carolis, E. D., Criscuolo, M., Ballanti, S., Angelis, G. D., Principe, M. I. D., Delia, M., Fracchiolla, N., Marchesi, F., Nadali, G., et al. (2020) · Mycoses · doi:10.1111/myc.13130 · Cited by 37
Müderris, T., Kaya, S., Örmen, B., Gökmen, A. A., Akpınar, C. V., & Gül, S. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101008 · Cited by 37
Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
Martínez-Herrera, E. O., León, M. G. F.-D., Hernández‐Castro, R., García-Salazar, E., Arenas, R., Ocharan-Hernández, M. E., & Rodríguez‐Cerdeira, C. (2021) · Journal of Fungi · doi:10.3390/jof8010014 · Cited by 37
Pfaller, M. A., Carvalhaes, C. G., DeVries, S. D., Rhomberg, P. R., & Castanheira, M. (2022) · Medical Mycology · doi:10.1093/mmy/myac028 · Cited by 37
Self-citationAdministration and Dosing of Systemic Antifungal Agents in Pediatric Patients
Downes, K. J., Fisher, B. T., & Zane, N. R. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00379-2 · Cited by 37
Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity
Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., Joseph, L., & Asadzadeh, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240426 · Cited by 37
Hu, T., Wang, S., Bing, J., Zheng, Q., Du, H., Li, C., Guan, Z., Bai, F., Nobile, C. J., Chu, H., et al. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.107010 · Cited by 37
Nanomaterial-based therapeutics for enhanced antifungal therapy
Liu, F., Chen, Y., Huang, Y., Jin, Q., & Ji, J. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01484g · Cited by 37
Lima, S. L., Francisco, E. C., de Almeida, J. N., Santos, D. W. D. C. L., Carlesse, F., Queiroz‐Telles, F., Melo, A. S. D. A., & Colombo, A. L. (2020) · Journal of Fungi · doi:10.3390/jof6030110 · Cited by 36
Mete, B., Zerdali, E. Y., Aygün, G., Saltoğlu, N., Balkan, İ. İ., Karaali, R., Kaya, S. Y., Karaismailoglu, B., Kaya, A., Ürkmez, S., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03994-6 · Cited by 36
Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole
Bezerra, C. F., Júnior, J. G. D. A. S., Honorato, R. D. L., dos Santos, A. T. L., da Silva, J. C. P., da Silva, T. G., Leal, A. L. A. B., Rocha, J. E., de Freitas, T. S., Vieira, T. A. T., et al. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104987 · Cited by 36
Candida glabrata is a successful pathogen: An artist manipulating the immune response
Castrejón-Jiménez, N. S., Castillo-Cruz, J., Baltierra‐Uribe, S. L., Hernández-González, J. C., & Estela, G.-P. B. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127038 · Cited by 37
Badiee, P., Boekhout, T., Haddadi, P., Mohammadi, R., Ghadimi-Moghadam, A., Soltani, J., Mahmoudabadi, A. Z., Mousavi, S. A. A., Najafzadeh, M. J., Diba, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02453-22 · Cited by 36
Fan, X., Tsui, C. K. M., Chen, X., Wang, P., Liu, Z.-J., & Yang, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125241 · Cited by 36
Antifungals in Clinical Use and the Pipeline
Johnson, M. D. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.005 · Cited by 35
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways
Hetta, H. F., Melhem, T., Aljohani, H. M., Salama, A., Ahmed, R., Elfadil, H., Alanazi, F. E., Ramadan, Y. N., Battah, B., Rottura, M., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18030364 · Cited by 35
Epidemiology of Candidemia in Kuwait: A Nationwide, Population-Based Study
Alobaid, K., Ahmad, S., Asadzadeh, M., Mokaddas, E. M., Al‐Sweih, N., Benwan, K. A., Alfouzan, W. A., Al‐Obaid, I., Jeragh, A., Al-Roomi, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080673 · Cited by 35
Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
Zhen, C., Lu, H., & Jiang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.911322 · Cited by 36
Treatment of invasive candidiasis in the era of Candida resistance
Paiva, J.-A., & Pereira, J. M. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001077 · Cited by 35
Franconi, I., Rizzato, C., Tavanti, A., Falcone, M., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9101012 · Cited by 35
Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host
Wahab, A., Sanborn, D., Vergidis, P. I., Razonable, R. R., Yadav, H., & Pennington, K. M. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.08.046 · Cited by 35
Odoj, K., Garlasco, J., Pezzani, M. D., Magnabosco, C., Ortiz, D., Manco, F., Galia, L., Foster, S. K., Arieti, F., & Tacconelli, E. (2024) · Journal of Fungi · doi:10.3390/jof10100685 · Cited by 34
Andes, D. R., Brüggemann, R. J. M., Flanagan, S., Lepak, A. J., Lewis, R. E., Ong, V. S., Rubino, C. M., & Sandison, T. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae415 · Cited by 35
Fasolo, D., Pippi, B., Meirelles, G. D. C., Zorzi, G. K., Fuentefría, A. M., von Poser, G. L., & Teixeira, H. F. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101573 · Cited by 34
Rodrigues, D. K. D. B., Bonfietti, L. X., Garcia, R. A., Araújo, M. R., Rodrigues, J. S., Gimenes, V. M. F., & Melhem, M. D. S. C. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2020e10928 · Cited by 34
Khalifa, H. O., Watanabe, A., & Kamei, K. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.004 · Cited by 34
Partha, A. D. S. L., Widodo, A. D. W., & Endraswari, P. D. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104882 · Cited by 34
Rasheed, M., Battu, A., & Kaur, R. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792773 · Cited by 33
de Oliveira, C. S., Colombo, A. L., Francisco, E. C., de Lima, B., Gandra, R. F., de Carvalho, M. C. P., Carrilho, C. M. D. D. M., Petinelli, R. P., Pelisson, M., Helbel, C., et al. (2020) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2020.11.006 · Cited by 33
The two-component signal transduction system and its regulation in Candida albicans
Liao, B., Ye, X., Chen, X., Zhou, Y., Cheng, L., Zhou, X., & Ren, B. (2021) · Virulence · doi:10.1080/21505594.2021.1949883 · Cited by 33
da Silva Dantas, A., Nogueira, F., Lee, K. K., Walker, L. A., Edmondson, M., Brand, A. C., Lenardon, M. D., & Gow, N. A. R. (2021) · Journal of Cell Science · doi:10.1242/jcs.258889 · Cited by 31
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 32
Caspofungin: a review of its characteristics, activity, and use in intensive care units
Hashemian, S. M. R., Farhadi, T., & Velayati, A. A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1794817 · Cited by 31
Guo, J., Zhang, M., Qiao, D., Shen, H., Wang, L., Wang, D., Li, L., Liu, Y., Lu, H., Wang, C., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.644000 · Cited by 31
Antifungal stewardship in solid organ transplantation
Kriegl, L., Boyer, J., Egger, M., & Hoenigl, M. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13855 · Cited by 31
Haq, I. U., Maryam, S., Shyntum, D. Y., Khan, T. A., & Li, F. (2024) · Journal of Industrial Microbiology & Biotechnology · doi:10.1093/jimb/kuae018 · Cited by 32
Metadata
- Authors
- Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N.
- Affiliations
- University of Iowa (US)
- The University of Adelaide (AU)
- JMI Laboratories (US)
- Corresponding author
- Pfaller, Michael A
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03
- Volume
- 6
- Issue
- Supplement_1
- Pages
- S79-S94
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC6419901
- OpenAlex
- W2922388167
- Semantic Scholar
- b99f36f4463b9afe6d2a0ab52eebb3f5e726f4c0
- Cited by
- 825
- References
- 114
- Citations by year
- 2026: 92 · 2025: 129 · 2024: 133 · 2023: 141 · 2022: 94 · 2021: 108 · 2020: 104 · 2019: 24
- FWCI
- 63.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- JMI Laboratories
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- invasive candidiasis, Candida species, antifungal resistance, fluconazole resistance, echinocandin resistance, Candida glabrata, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida auris, micafungin resistance, caspofungin, anidulafungin, Candida species distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.